BackGoodRx Holdings Overview
GoodRx Holdings Inc - Ordinary Shares - Class A

GoodRx Holdings Target Price

Analysts' average 12-month price target for GoodRx Holdings is $4.2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.56

Average Target Price

$4.1917.6% upside

4 analysts in the last 4 months

High: $5 | Low: $3.75

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-20Barclays$412.4% upsideOpen
2026-08-13UBS$3.755.3% upsideOpen
2026-08-07Goldman Sachs$412.4% upsideOpen
2026-08-06Leerink Partners$540.4% upsideOpen
2026-05-08Goldman SachsEric Sheridan$3.51.7% downsideOpen
2026-02-26Leerink PartnersMichael Cherny$315.7% downsideOpen
2026-01-22JefferiesGlen Santangelo$2.7522.8% downsideOpen
2025-12-18Morgan Stanley$412.4% upsideOpen
2025-12-08Barclays$315.7% downsideOpen
2025-08-11Deutsche BankGeorge Hill$668.5% upsideOpen
2024-06-10Morgan StanleyCraig Hettenbach$9.5166.9% upsideOpen
2024-05-23RBC CapitalMark Mahaney$10180.9% upsideOpen
2024-05-16BarclaysStephanie Davis$9152.8% upsideOpen
2024-05-16Raymond JamesAaron Kessler$10180.9% upsideOpen
2024-04-10BOCOM International Holdings CompanyScott Schoenhaus$9152.8% upsideOpen
2024-04-10KeyBancScott Schoenhaus$9152.8% upsideOpen
2024-03-25Wells FargoStan Berenshteyn$10180.9% upsideOpen
2023-11-13Goldman SachsEric Sheridan$315.7% downsideOpen
2022-12-01Citigroup$796.6% upsideOpen
2022-08-09BarclaysSteve Valiquette$13265.2% upsideOpen
2022-06-07Robert W. BairdVikram Kesavabhotla$796.6% upsideOpen
2022-05-12Wells FargoStan Berenshteyn$9152.8% upsideOpen
2022-03-01J.P. MorganDoug Anmuth$20461.8% upsideOpen
2022-03-01Cowen & Co.Charles Rhyee$22518% upsideOpen
2022-03-01Goldman SachsEric Sheridan$30742.7% upsideOpen
2022-03-01Deutsche BankGeorge Hill$20461.8% upsideOpen
2022-03-01Bank of America SecuritiesJustin Post$28686.5% upsideOpen
2021-12-21StephensScott Schoenhaus$451164% upsideOpen
2021-05-14CitigroupNicholas Jones CFA$531388.8% upsideOpen

GoodRx Holdings (GDRX) FAQ

As of the most recent data, GDRX shows a target price of $4.2. Scroll down for historical charts and peer comparison views.

If GoodRx Holdings moved to the average analyst target of $4.2, shares would be roughly 17.6% higher than $3.56. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of GoodRx Holdings's earnings trajectory.

Besides this target price page, Stockcircle has GoodRx Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $4.2) with ownership activity and broader fundamentals.

GoodRx Holdings's target price is $4.2; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.